Not Medicare Enrolled

Dr. Mary Geldernick, MD

Obstetrics & Gynecology · New Braunfels, TX
Low-engagement
505 N UNION AV, New Braunfels, TX 78130
8306296462
In practice since 2006 (19 years)
NPI: 1104987510 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Geldernick from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Geldernick? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Geldernick

Dr. Mary Geldernick is an obstetrics & gynecology specialist in New Braunfels, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Geldernick received a total of $2,480 from 38 pharmaceutical and/or device companies across 173 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in obstetrics & gynecology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Geldernick is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $2,480 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,480
Total received (2018-2024)
Avg $354/year across 7 years
Top 28% in TX for obstetrics & gynecology
38
Companies
173
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,432 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$48 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$286
2023
$123
2022
$313
2021
$404
2020
$217
2019
$572
2018
$565

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$305
Avion Pharmaceuticals
$292
Duchesnay USA Incorporated
$217
MAYNE PHARMA COMMERCIAL LLC
$148
Agile Therapeutics, Inc.
$134
TherapeuticsMD, Inc.
$120
AbbVie, Inc.
$109
Roche Diagnostics Corporation
$96
Allergan Inc.
$89
AbbVie Inc.
$74
Myovant Sciences Inc.
$71
Mylan Pharmaceuticals Inc.
$62
Radius Health, Inc.
$57
ABBVIE INC.
$55
AMAG Pharmaceuticals, Inc.
$48
Exeltis, USA Inc.
$44
PFIZER INC.
$41
MAYNE PHARMA INC.
$38
CooperSurgical, Inc.
$37
Lupin Inc.
$36
MILLICENT US INC
$35
IDORSIA PHARMACEUTICALS US INC
$34
Currax Pharmaceuticals LLC
$30
Ferring Pharmaceuticals Inc.
$30
Vermillion, Inc.
$27
Orexigen Therapeutics, Inc.
$27
Lilly USA, LLC
$27
Allergan, Inc.
$25
Avanos Medical
$24
Shield Therapeutics Inc
$22
Becton, Dickinson and Company
$18
Astellas Pharma US Inc
$17
ASCEND Therapeutics US, LLC
$16
Vertical Pharmaceuticals, LLC
$16
Nalpropion Pharmaceuticals LLC
$14
Aspira Women's Health Inc
$14
Hologic, LLC
$14
Novo Nordisk Inc
$14
Top 3 companies account for 32.8% of total payments
Associated products mentioned in payments ›
AC2 · ACCRUFER · ANNOVERA · BIJUVA · Balcoltra · CERVIDIL · CONTRAVE · DIVIGEL · EMGALITY · ESTROGEL · EVENITY · Endosee · FEMRING · FORTEO · Femring · IMVEXXY · INTRAROSA · LO LOESTRIN FE · MYFEMBREE · Myrbetriq · ON-Q* PUMP AND ACCESSORIES · ORIAHNN · ORILISSA · OVA1 · Orilissa · Osphena · PREMARIN · Paragard T 380A · Prolia · QUVIVIQ · RS Harmony Test Related Products · SLYND · SOLOSEC · Saxenda · Synthroid · Twirla · Tymlos · UBRELVY · Xulane
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an obstetrics & gynecology specialist in New Braunfels?
Compare obstetricians & gynecologists in the New Braunfels area by procedure volume, costs, and industry payment transparency.
Browse obstetricians & gynecologists nearby

Geographic Context

Obstetricians & gynecologists within 10 mi
49
Per 100K population
27.5
County median income
$93,776
Nearest hospital
RESOLUTE HEALTH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Geldernick is an obstetrics & gynecology specialist, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Geldernick receive payments from pharmaceutical companies?
Yes. Dr. Geldernick received a total of $2,480 from 38 companies across 173 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Geldernick) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →